| __timestamp | Supernus Pharmaceuticals, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5758000 | 54823000000 |
| Thursday, January 1, 2015 | 8423000 | 76691000000 |
| Friday, January 1, 2016 | 11986000 | 87477000000 |
| Sunday, January 1, 2017 | 15215000 | 89052000000 |
| Monday, January 1, 2018 | 15356000 | 100745000000 |
| Tuesday, January 1, 2019 | 16660000 | 91915000000 |
| Wednesday, January 1, 2020 | 52459000 | 95905000000 |
| Friday, January 1, 2021 | 75061000 | 104442000000 |
| Saturday, January 1, 2022 | 87221000 | 104437000000 |
| Sunday, January 1, 2023 | 83779000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost structures is pivotal. Walgreens Boots Alliance, Inc., a retail giant, and Supernus Pharmaceuticals, Inc., a niche player, present contrasting cost narratives from 2014 to 2023. Walgreens consistently reported a cost of revenue exceeding $54 billion annually, peaking at $112 billion in 2023, reflecting its expansive retail operations. In contrast, Supernus, with a more focused pharmaceutical approach, saw its costs rise from $5.8 million in 2014 to $87 million in 2022, marking a staggering 1,400% increase. This divergence highlights the scale and operational differences between a global retailer and a specialized pharmaceutical firm. Notably, 2024 data for Supernus is missing, indicating potential reporting delays or strategic shifts. These insights underscore the importance of cost management in sustaining competitive advantage in diverse market environments.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Biogen Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for United Therapeutics Corporation and Walgreens Boots Alliance, Inc.
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Perrigo Company plc
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: ADMA Biologics, Inc. vs Supernus Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and Xencor, Inc.